The Drug Delivery Devices Market was valued at USD 432.4 Billion in 2024, and is projected to reach USD 667.4 Billion by 2030, rising at a CAGR of 7.50%. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to drive the market. ![Drug Delivery Devices Market]( "Drug Delivery Devices Market")
Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehicles such as liposomes, nanoparticles, and micelle are also being developed for various applications.
Key players present in the market are adopting various strategies such as mergers and acquisitions, partnership, and collaborations to develop and improve drug delivery devices for various applications. Moreover, end-users are also forming partnerships with companies to acquire drug delivery devices for training purpose and research studies. In addition, market players are also forming distribution agreement to expand the reach of their products. Therefore, alliances made by the players are expected to drive the market growth during the forecast period.
Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehicles such as liposomes, nanoparticles, and micelle are also being developed for various applications.
Key players present in the market are adopting various strategies such as mergers and acquisitions, partnership, and collaborations to develop and improve drug delivery devices for various applications. Moreover, end-users are also forming partnerships with companies to acquire drug delivery devices for training purpose and research studies. In addition, market players are also forming distribution agreement to expand the reach of their products. Therefore, alliances made by the players are expected to drive the market growth during the forecast period.
Drug Delivery Devices Market Report Highlights
- The inhalers segment leads the market with a share of 23.9% in 2024, driven by the demand for asthma treatment. However, conventional metered-dose inhalers contribute significantly to greenhouse gas emissions.
- The drug delivery devices segment for diabetes dominated the market in 2024 with a share of 21.1%.
- The hospitals segment held the largest market share in 2024 with a share of 29.0%, driven by the rising demand for surgical interventions and preventive procedures.
- The North America drug delivery devices market dominated the overall global market and accounted for the 32.4% revenue share in 2024.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.21. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.21. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.3. Regional outlook
2.4. Competitive Insights
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing demand for novel drug delivery devices
3.2.1.2. Increasing prevalence of chronic diseases
3.2.1.3. Technological advancement in drug delivery devices
3.2.1.4. Growing strategic alliances for drug delivery devices
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges associated with various routes of drug delivery devices
3.3. Drug Delivery Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing demand for novel drug delivery devices
3.2.1.2. Increasing prevalence of chronic diseases
3.2.1.3. Technological advancement in drug delivery devices
3.2.1.4. Growing strategic alliances for drug delivery devices
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges associated with various routes of drug delivery devices
3.3. Drug Delivery Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Drug Delivery Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Drug Delivery Devices Market: Product Movement Analysis
4.3. Drug Delivery Devices Market by Product Outlook (USD Billion)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
4.5. Inhalers
4.5.1. Inhalers Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.5.1.1. Metered-dose inhalers (MDIs)
4.5.1.1.1. Metered-dose inhalers (MDIs) Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.5.1.2. Dry powder inhalers (DPIs)
4.5.1.2.1. Dry powder inhalers (DPIs) Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.5.1.3. Others
4.5.1.3.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.6. Injection Devices
4.6.1. Injection Devices Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.6.1.1. Prefilled Syringes
4.6.1.1.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.6.1.2. Auto-injectors
4.6.1.2.1. Auto-injectors Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.6.1.3. Pen Injectors
4.6.1.3.1. Pen Injectors Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.6.1.4. Needle-free Injectors
4.6.1.4.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.6.1.5. Wearable Injectors
4.6.1.5.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.7. Implants
4.7.1. Implants Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.7.1.1. Contraceptive Implants
4.7.1.1.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.7.1.2. Drug-eluting Stents
4.7.1.2.1. Drug-eluting Stents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.7.1.3. Biodegradable Implants
4.7.1.3.1. Biodegradable Implants Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.8. Topical Delivery System
4.8.1. Topical Delivery System Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.8.1.1. Creams
4.8.1.1.1. Creams Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.8.1.2. Gels
4.8.1.2.1. Gels Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.8.1.3. Ointments
4.8.1.3.1. Ointments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.9. Oral Delivery System
4.9.1. Oral Delivery System Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.9.1.1. Controlled-release Tablets and Capsules
4.9.1.1.1. Controlled-release Tablets and Capsules Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.9.1.2. Buccal and Sublingual Tablets
4.9.1.2.1. Buccal and Sublingual Tablets Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.10. Occular Delivery System
4.10.1. Occular Delivery System Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.11. Nebulizers
4.11.1. Nebulizers Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.12. Transdermal Patches
4.12.1. Transdermal Patches Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.13. Infusion Pumps
4.13.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.2. Drug Delivery Devices Market: Product Movement Analysis
4.3. Drug Delivery Devices Market by Product Outlook (USD Billion)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
4.5. Inhalers
4.5.1. Inhalers Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.5.1.1. Metered-dose inhalers (MDIs)
4.5.1.1.1. Metered-dose inhalers (MDIs) Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.5.1.2. Dry powder inhalers (DPIs)
4.5.1.2.1. Dry powder inhalers (DPIs) Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.5.1.3. Others
4.5.1.3.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.6. Injection Devices
4.6.1. Injection Devices Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.6.1.1. Prefilled Syringes
4.6.1.1.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.6.1.2. Auto-injectors
4.6.1.2.1. Auto-injectors Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.6.1.3. Pen Injectors
4.6.1.3.1. Pen Injectors Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.6.1.4. Needle-free Injectors
4.6.1.4.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.6.1.5. Wearable Injectors
4.6.1.5.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.7. Implants
4.7.1. Implants Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.7.1.1. Contraceptive Implants
4.7.1.1.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.7.1.2. Drug-eluting Stents
4.7.1.2.1. Drug-eluting Stents Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.7.1.3. Biodegradable Implants
4.7.1.3.1. Biodegradable Implants Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.8. Topical Delivery System
4.8.1. Topical Delivery System Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.8.1.1. Creams
4.8.1.1.1. Creams Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.8.1.2. Gels
4.8.1.2.1. Gels Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.8.1.3. Ointments
4.8.1.3.1. Ointments Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.9. Oral Delivery System
4.9.1. Oral Delivery System Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.9.1.1. Controlled-release Tablets and Capsules
4.9.1.1.1. Controlled-release Tablets and Capsules Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.9.1.2. Buccal and Sublingual Tablets
4.9.1.2.1. Buccal and Sublingual Tablets Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.10. Occular Delivery System
4.10.1. Occular Delivery System Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.11. Nebulizers
4.11.1. Nebulizers Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.12. Transdermal Patches
4.12.1. Transdermal Patches Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.13. Infusion Pumps
4.13.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 5. Drug Delivery Devices Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Drug Delivery Devices Market: Application Movement Analysis
5.3. Drug Delivery Devices Market by Application Outlook (USD Billion)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
5.5. Oncology
5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.6. Infectious Diseases
5.6.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.7. Respiratory Diseases
5.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.8. Diabetes
5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.9. Cardiovascular Diseases
5.9.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.10. Autoimmune Diseases
5.10.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.11. Central Nervous System Disorders
5.11.1. Central Nervous System Disorders Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.12. Others
5.12.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.2. Drug Delivery Devices Market: Application Movement Analysis
5.3. Drug Delivery Devices Market by Application Outlook (USD Billion)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
5.5. Oncology
5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.6. Infectious Diseases
5.6.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.7. Respiratory Diseases
5.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.8. Diabetes
5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.9. Cardiovascular Diseases
5.9.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.10. Autoimmune Diseases
5.10.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.11. Central Nervous System Disorders
5.11.1. Central Nervous System Disorders Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.12. Others
5.12.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 6. Drug Delivery Devices Market: End-use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Drug Delivery Devices Market: End-use Movement Analysis
6.3. Drug Delivery Devices Market by End-use Outlook (USD Billion)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
6.5. Hospitals
6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.6. Diagnostic Centers
6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.7. Ambulatory Surgery Centers/Clinics
6.7.1. Ambulatory Surgery Centers/Clinics Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.8. Home Care Settings
6.8.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.9. Others
6.9.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.2. Drug Delivery Devices Market: End-use Movement Analysis
6.3. Drug Delivery Devices Market by End-use Outlook (USD Billion)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
6.5. Hospitals
6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.6. Diagnostic Centers
6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.7. Ambulatory Surgery Centers/Clinics
6.7.1. Ambulatory Surgery Centers/Clinics Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.8. Home Care Settings
6.8.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.9. Others
6.9.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Regional Drug Delivery Devices Market Movement Analysis
7.3. Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
7.5. North America
7.5.1. North America Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement scenario
7.5.2.5. U.S. Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.3. Canada
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Canada Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement scenario
7.5.4.5. Mexico Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.5. Europe
7.5.6. Europe Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.7. UK
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement scenario
7.5.7.5. UK Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.8. Germany
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement scenario
7.5.8.5. Germany Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.9. France
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement scenario
7.5.9.5. France Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.10. Italy
7.5.10.1. Key Country Dynamics
7.5.10.2. Competitive Scenario
7.5.10.3. Regulatory Framework
7.5.10.4. Reimbursement scenario
7.5.10.5. Italy Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.11. Spain
7.5.11.1. Key Country Dynamics
7.5.11.2. Competitive Scenario
7.5.11.3. Regulatory Framework
7.5.11.4. Reimbursement scenario
7.5.11.5. Spain Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.12. Denmark
7.5.12.1. Key Country Dynamics
7.5.12.2. Competitive Scenario
7.5.12.3. Regulatory Framework
7.5.12.4. Reimbursement scenario
7.5.12.5. Denmark Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.13. Sweden
7.5.13.1. Key Country Dynamics
7.5.13.2. Competitive Scenario
7.5.13.3. Regulatory Framework
7.5.13.4. Reimbursement scenario
7.5.13.5. Sweden Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.14. Norway
7.5.14.1. Key Country Dynamics
7.5.14.2. Competitive Scenario
7.5.14.3. Regulatory Framework
7.5.14.4. Reimbursement scenario
7.5.14.5. Norway Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6. Asia Pacific
7.6.1. Asia Pacific Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement scenario
7.6.2.5. Japan Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement scenario
7.6.3.5. China Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement scenario
7.6.4.5. India Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement scenario
7.6.5.5. South Korea Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Australia Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement scenario
7.6.7.5. Thailand Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.7. Latin America
7.7.1. Latin America Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Brazil Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement scenario
7.7.3.5. Argentina Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement scenario
7.8.2.5. South Africa Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement scenario
7.8.3.5. Saudi Arabia Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement scenario
7.8.4.5. UAE Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Kuwait Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.2. Regional Drug Delivery Devices Market Movement Analysis
7.3. Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
7.5. North America
7.5.1. North America Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement scenario
7.5.2.5. U.S. Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.3. Canada
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Canada Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement scenario
7.5.4.5. Mexico Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.5. Europe
7.5.6. Europe Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.7. UK
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement scenario
7.5.7.5. UK Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.8. Germany
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement scenario
7.5.8.5. Germany Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.9. France
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement scenario
7.5.9.5. France Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.10. Italy
7.5.10.1. Key Country Dynamics
7.5.10.2. Competitive Scenario
7.5.10.3. Regulatory Framework
7.5.10.4. Reimbursement scenario
7.5.10.5. Italy Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.11. Spain
7.5.11.1. Key Country Dynamics
7.5.11.2. Competitive Scenario
7.5.11.3. Regulatory Framework
7.5.11.4. Reimbursement scenario
7.5.11.5. Spain Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.12. Denmark
7.5.12.1. Key Country Dynamics
7.5.12.2. Competitive Scenario
7.5.12.3. Regulatory Framework
7.5.12.4. Reimbursement scenario
7.5.12.5. Denmark Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.13. Sweden
7.5.13.1. Key Country Dynamics
7.5.13.2. Competitive Scenario
7.5.13.3. Regulatory Framework
7.5.13.4. Reimbursement scenario
7.5.13.5. Sweden Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.14. Norway
7.5.14.1. Key Country Dynamics
7.5.14.2. Competitive Scenario
7.5.14.3. Regulatory Framework
7.5.14.4. Reimbursement scenario
7.5.14.5. Norway Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6. Asia Pacific
7.6.1. Asia Pacific Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement scenario
7.6.2.5. Japan Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement scenario
7.6.3.5. China Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement scenario
7.6.4.5. India Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement scenario
7.6.5.5. South Korea Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Australia Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement scenario
7.6.7.5. Thailand Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.7. Latin America
7.7.1. Latin America Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Brazil Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement scenario
7.7.3.5. Argentina Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement scenario
7.8.2.5. South Africa Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement scenario
7.8.3.5. Saudi Arabia Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement scenario
7.8.4.5. UAE Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Kuwait Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Gerresheimer AG
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. W. L. Gore & Associates, Inc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Abbott
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Terumo Medical Corporation
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Stryker
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Medtronic
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Boston Scientific Corporation
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Novartis AG
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Becton, Dickinson and Company
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Teleflex Incorporated
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2. Key Company Profiles
8.2.1. Gerresheimer AG
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. W. L. Gore & Associates, Inc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Abbott
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Terumo Medical Corporation
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Stryker
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Medtronic
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Boston Scientific Corporation
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Novartis AG
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Becton, Dickinson and Company
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Teleflex Incorporated
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. North America drug delivery devices market, by country, 2018-2030 (USD Billion)
Table 4. North America drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 5. North America drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 6. North America drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 7. U.S. drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 8. U.S. drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 9. U.S. drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 10. Canada drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 11. Canada drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 12. Canada drug delivery devices market, by end-use, (USD Billion) 2018-2030
Table 13. Mexico drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 14. Mexico drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 15. Mexico drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 16. Europe drug delivery devices market, by region, 2018-2030 (USD Billion)
Table 17. Europe drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 18. Europe drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 19. Europe drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 20. Germany drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 21. Germany drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 22. Germany drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 23. U.K. drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 24. U.K. drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 25. U.K. drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 26. France drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 27. France drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 28. France drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 29. Italy drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 30. Italy drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 31. Italy drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 32. Spain drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 33. Spain drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 34. Spain drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 35. Denmark drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 36. Denmark drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 37. Denmark drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 38. Sweden drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 39. Sweden drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 40. Sweden drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 41. Norway drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 42. Norway drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 43. Norway drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 44. APAC drug delivery devices market, by region, 2018-2030 (USD Billion)
Table 45. APAC drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 46. APAC drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 47. APAC drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 48. China drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 49. China drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 50. China drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 51. Japan drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 52. Japan drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 53. Japan drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 54. India drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 55. India drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 56. India drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 57. Thailand drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 58. Thailand drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 59. Thailand drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 60. South Korea drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 61. South Korea drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 62. South Korea drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 63. Australia drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 64. Australia drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 65. Australia drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 66. Latin America drug delivery devices market, by region, 2018-2030 (USD Billion)
Table 67. Latin America drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 68. Latin America drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 69. Latin America drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 70. Brazil drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 71. Brazil drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 72. Brazil drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 73. Argentina drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 74. Argentina drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 75. Argentina drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 76. Middle East and Africa drug delivery devices market, by region, 2018-2030 (USD Billion)
Table 77. Middle East and Africa drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 78. Middle East and Africa drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 79. Middle East and Africa drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 80. South Africa drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 81. South Africa drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 82. South Africa drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 83. Saudi Arabia drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 84. Saudi Arabia drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 85. Saudi Arabia drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 86. UAE drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 87. UAE drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 88. UAE drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 89. Kuwait drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 90. Kuwait drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 91. Kuwait drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 2. List of Abbreviations
Table 3. North America drug delivery devices market, by country, 2018-2030 (USD Billion)
Table 4. North America drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 5. North America drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 6. North America drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 7. U.S. drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 8. U.S. drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 9. U.S. drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 10. Canada drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 11. Canada drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 12. Canada drug delivery devices market, by end-use, (USD Billion) 2018-2030
Table 13. Mexico drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 14. Mexico drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 15. Mexico drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 16. Europe drug delivery devices market, by region, 2018-2030 (USD Billion)
Table 17. Europe drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 18. Europe drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 19. Europe drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 20. Germany drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 21. Germany drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 22. Germany drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 23. U.K. drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 24. U.K. drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 25. U.K. drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 26. France drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 27. France drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 28. France drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 29. Italy drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 30. Italy drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 31. Italy drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 32. Spain drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 33. Spain drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 34. Spain drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 35. Denmark drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 36. Denmark drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 37. Denmark drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 38. Sweden drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 39. Sweden drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 40. Sweden drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 41. Norway drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 42. Norway drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 43. Norway drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 44. APAC drug delivery devices market, by region, 2018-2030 (USD Billion)
Table 45. APAC drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 46. APAC drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 47. APAC drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 48. China drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 49. China drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 50. China drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 51. Japan drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 52. Japan drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 53. Japan drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 54. India drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 55. India drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 56. India drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 57. Thailand drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 58. Thailand drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 59. Thailand drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 60. South Korea drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 61. South Korea drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 62. South Korea drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 63. Australia drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 64. Australia drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 65. Australia drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 66. Latin America drug delivery devices market, by region, 2018-2030 (USD Billion)
Table 67. Latin America drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 68. Latin America drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 69. Latin America drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 70. Brazil drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 71. Brazil drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 72. Brazil drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 73. Argentina drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 74. Argentina drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 75. Argentina drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 76. Middle East and Africa drug delivery devices market, by region, 2018-2030 (USD Billion)
Table 77. Middle East and Africa drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 78. Middle East and Africa drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 79. Middle East and Africa drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 80. South Africa drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 81. South Africa drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 82. South Africa drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 83. Saudi Arabia drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 84. Saudi Arabia drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 85. Saudi Arabia drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 86. UAE drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 87. UAE drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 88. UAE drug delivery devices market, by end-use, 2018-2030 (USD Billion)
Table 89. Kuwait drug delivery devices market, by product, 2018-2030 (USD Billion)
Table 90. Kuwait drug delivery devices market, by application, 2018-2030 (USD Billion)
Table 91. Kuwait drug delivery devices market, by end-use, 2018-2030 (USD Billion)
List of Figures
Figure 1 Information Procurement
Figure 2 Primary Research Pattern
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 Drug delivery devices market segmentation
Figure 7 Market driver analysis (Current & future impact)
Figure 8 Market restraint analysis (Current & future impact)
Figure 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 10 Porter’s Five Forces Analysis
Figure 11 Drug delivery devices market, Product outlook key takeaways (USD Billion)
Figure 12 Drug delivery devices market Product movement analysis 2023 & 2030 (USD Billion)
Figure 13 Inhalers market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 14 Metered-dose inhalers (MDIs) market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 15 Dry powder inhalers (DPIs) market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 16 Others market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 17 Injection devices market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 18 Prefilled syringes market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 19 Auto-injectors market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 20 Pen injectors market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 21 Needle-free injectors market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 22 Wearable injectors market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 23 Implants market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 24 Contraceptive implants market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 25 Drug-eluting stents market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 26 Biodegradable implants market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 27 Topical delivery system market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 28 Creams market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 29 Gels market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 30 Ointments market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 31 Oral delivery system market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 32 Controlled-release tablets and capsules market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 33 Buccal and sublingual tablets market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 34 Occular delivery system market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 35 Nebulizers market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 36 Transdermal patches market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 37 Infusion pumps market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 38 Drug delivery devices market, application outlook key takeaways (USD Billion)
Figure 39 Drug delivery devices market application movement analysis 2023 & 2030 (USD Billion)
Figure 40 Oncology market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 41 Infectious diseases market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 42 Respiratory diseases market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 43 Diabetes market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 44 Cardiovascular diseases market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 45 Autoimmune diseases market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 46 Central nervous system disorders market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 47 Others market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 48 Drug delivery devices market, end use outlook key takeaways (USD Billion)
Figure 49 Drug delivery devices market, end use movement analysis 2023 & 2030 (USD Billion)
Figure 50 Hospitals market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 51 Diagnostic centers market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 52 Ambulatory surgery centers/clinics market, application outlook key takeaways (USD Billion)
Figure 53 Home care settings market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 54 Others market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 55 Drug delivery devices market: Regional key takeaways (USD Billion)
Figure 56 Drug delivery devices market regional outlook, 2023 & 2030 (USD Billion)
Figure 57 North America drug delivery devices estimates and forecasts, 2018-2030 (USD Billion)
Figure 58 US drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 59 Canada drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 60 Mexico drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 61 Europe drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 62 UK drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 63 Germany drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 64 France drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 65 Spain drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 66 Italy drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 67 Sweden drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 68 Norway drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 69 Denmark drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 70 Asia Pacific drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 71 China drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 72 Japan drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 73 India drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 74 South Korea drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 75 Australia drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 76 Thailand drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 77 Latin America drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 78 Brazil drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 79 Argentina drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 80 Middle East and Africa drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 81 South Africa drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 82 Saudi Arabia drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 83 UAE drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 84 Kuwait drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 85 List of key emerging company’s/distribution channel disruptors/innovators
Figure 2 Primary Research Pattern
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 Drug delivery devices market segmentation
Figure 7 Market driver analysis (Current & future impact)
Figure 8 Market restraint analysis (Current & future impact)
Figure 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 10 Porter’s Five Forces Analysis
Figure 11 Drug delivery devices market, Product outlook key takeaways (USD Billion)
Figure 12 Drug delivery devices market Product movement analysis 2023 & 2030 (USD Billion)
Figure 13 Inhalers market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 14 Metered-dose inhalers (MDIs) market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 15 Dry powder inhalers (DPIs) market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 16 Others market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 17 Injection devices market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 18 Prefilled syringes market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 19 Auto-injectors market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 20 Pen injectors market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 21 Needle-free injectors market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 22 Wearable injectors market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 23 Implants market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 24 Contraceptive implants market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 25 Drug-eluting stents market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 26 Biodegradable implants market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 27 Topical delivery system market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 28 Creams market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 29 Gels market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 30 Ointments market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 31 Oral delivery system market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 32 Controlled-release tablets and capsules market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 33 Buccal and sublingual tablets market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 34 Occular delivery system market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 35 Nebulizers market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 36 Transdermal patches market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 37 Infusion pumps market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 38 Drug delivery devices market, application outlook key takeaways (USD Billion)
Figure 39 Drug delivery devices market application movement analysis 2023 & 2030 (USD Billion)
Figure 40 Oncology market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 41 Infectious diseases market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 42 Respiratory diseases market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 43 Diabetes market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 44 Cardiovascular diseases market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 45 Autoimmune diseases market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 46 Central nervous system disorders market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 47 Others market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 48 Drug delivery devices market, end use outlook key takeaways (USD Billion)
Figure 49 Drug delivery devices market, end use movement analysis 2023 & 2030 (USD Billion)
Figure 50 Hospitals market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 51 Diagnostic centers market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 52 Ambulatory surgery centers/clinics market, application outlook key takeaways (USD Billion)
Figure 53 Home care settings market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 54 Others market revenue estimates and forecasts, 2018-2030 (USD Billion)
Figure 55 Drug delivery devices market: Regional key takeaways (USD Billion)
Figure 56 Drug delivery devices market regional outlook, 2023 & 2030 (USD Billion)
Figure 57 North America drug delivery devices estimates and forecasts, 2018-2030 (USD Billion)
Figure 58 US drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 59 Canada drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 60 Mexico drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 61 Europe drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 62 UK drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 63 Germany drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 64 France drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 65 Spain drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 66 Italy drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 67 Sweden drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 68 Norway drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 69 Denmark drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 70 Asia Pacific drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 71 China drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 72 Japan drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 73 India drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 74 South Korea drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 75 Australia drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 76 Thailand drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 77 Latin America drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 78 Brazil drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 79 Argentina drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 80 Middle East and Africa drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 81 South Africa drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 82 Saudi Arabia drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 83 UAE drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 84 Kuwait drug delivery devices market estimates and forecasts, 2018-2030 (USD Billion)
Figure 85 List of key emerging company’s/distribution channel disruptors/innovators
Companies Mentioned
The companies profiled in this Drug Delivery Devices market report include:- Gerresheimer AG
- W. L. Gore & Associates, Inc.
- Abbott
- Terumo Medical Corporation
- Stryker
- Medtronic
- Boston Scientific Corporation
- Novartis AG
- Becton, Dickinson and Company
- Teleflex Incorporated
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 170 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 432.4 Billion |
| Forecasted Market Value ( USD | $ 667.4 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
